Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & EnergyDetailed TOC of Global Non-Alcoholic Steatohepatitis Treatment Market Research Report 2024
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Vitamin E and Pioglitazone
1.2.3 Obeticholic Acid (OCA)
1.2.4 Lanifibranor
1.2.5 Semaglutide
1.2.6 Resmetirom
1.2.7 Aramchol
1.2.8 Cenicriviroc
1.2.9 Others
1.3 Market by Application
1.3.1 Global Non-Alcoholic Steatohepatitis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail & Specialty Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Alcoholic Steatohepatitis Treatment Market Perspective (2019-2030)
2.2 Non-Alcoholic Steatohepatitis Treatment Growth Trends by Region
2.2.1 Global Non-Alcoholic Steatohepatitis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Non-Alcoholic Steatohepatitis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Non-Alcoholic Steatohepatitis Treatment Market Dynamics
2.3.1 Non-Alcoholic Steatohepatitis Treatment Industry Trends
2.3.2 Non-Alcoholic Steatohepatitis Treatment Market Drivers
2.3.3 Non-Alcoholic Steatohepatitis Treatment Market Challenges
2.3.4 Non-Alcoholic Steatohepatitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Alcoholic Steatohepatitis Treatment Players by Revenue
3.1.1 Global Top Non-Alcoholic Steatohepatitis Treatment Players by Revenue (2019-2024)
3.1.2 Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Non-Alcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Alcoholic Steatohepatitis Treatment Revenue
3.4 Global Non-Alcoholic Steatohepatitis Treatment Market Concentration Ratio
3.4.1 Global Non-Alcoholic Steatohepatitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Alcoholic Steatohepatitis Treatment Revenue in 2023
3.5 Non-Alcoholic Steatohepatitis Treatment Key Players Head office and Area Served
3.6 Key Players Non-Alcoholic Steatohepatitis Treatment Product Solution and Service
3.7 Date of Enter into Non-Alcoholic Steatohepatitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Alcoholic Steatohepatitis Treatment Breakdown Data by Type
4.1 Global Non-Alcoholic Steatohepatitis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Type (2025-2030)
5 Non-Alcoholic Steatohepatitis Treatment Breakdown Data by Application
5.1 Global Non-Alcoholic Steatohepatitis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Non-Alcoholic Steatohepatitis Treatment Market Size (2019-2030)
6.2 North America Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024)
6.4 North America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Alcoholic Steatohepatitis Treatment Market Size (2019-2030)
7.2 Europe Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024)
7.4 Europe Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Alcoholic Steatohepatitis Treatment Market Size (2019-2030)
9.2 Latin America Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024)
9.4 Latin America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Intercept Pharmaceuticals
11.1.1 Intercept Pharmaceuticals Company Detail
11.1.2 Intercept Pharmaceuticals Business Overview
11.1.3 Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Introduction
11.1.4 Intercept Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
11.1.5 Intercept Pharmaceuticals Recent Development
11.2 Galmed Pharmaceuticals
11.2.1 Galmed Pharmaceuticals Company Detail
11.2.2 Galmed Pharmaceuticals Business Overview
11.2.3 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Introduction
11.2.4 Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
11.2.5 Galmed Pharmaceuticals Recent Development
11.3 Inventiva Pharma
11.3.1 Inventiva Pharma Company Detail
11.3.2 Inventiva Pharma Business Overview
11.3.3 Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Introduction
11.3.4 Inventiva Pharma Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
11.3.5 Inventiva Pharma Recent Development
11.4 AbbVie Inc.
11.4.1 AbbVie Inc. Company Detail
11.4.2 AbbVie Inc. Business Overview
11.4.3 AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Introduction
11.4.4 AbbVie Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
11.4.5 AbbVie Inc. Recent Development
11.5 Galectin Therapeutics Inc.
11.5.1 Galectin Therapeutics Inc. Company Detail
11.5.2 Galectin Therapeutics Inc. Business Overview
11.5.3 Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Introduction
11.5.4 Galectin Therapeutics Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
11.5.5 Galectin Therapeutics Inc. Recent Development
11.6 Madrigal Pharmaceuticals
11.6.1 Madrigal Pharmaceuticals Company Detail
11.6.2 Madrigal Pharmaceuticals Business Overview
11.6.3 Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Introduction
11.6.4 Madrigal Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
11.6.5 Madrigal Pharmaceuticals Recent Development
11.7 NGM Biopharmaceuticals Inc.
11.7.1 NGM Biopharmaceuticals Inc. Company Detail
11.7.2 NGM Biopharmaceuticals Inc. Business Overview
11.7.3 NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Introduction
11.7.4 NGM Biopharmaceuticals Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
11.7.5 NGM Biopharmaceuticals Inc. Recent Development
11.8 Novo Nordisk A/S
11.8.1 Novo Nordisk A/S Company Detail
11.8.2 Novo Nordisk A/S Business Overview
11.8.3 Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Introduction
11.8.4 Novo Nordisk A/S Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
11.8.5 Novo Nordisk A/S Recent Development
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Detail
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Introduction
11.9.4 Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
11.9.5 Bristol Myers Squibb Recent Development
11.10 Gilead Sciences Inc.
11.10.1 Gilead Sciences Inc. Company Detail
11.10.2 Gilead Sciences Inc. Business Overview
11.10.3 Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Introduction
11.10.4 Gilead Sciences Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
11.10.5 Gilead Sciences Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Non-Alcoholic Steatohepatitis Treatment Market Research Report 2024
List of TablesTable 1. Global Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Vitamin E and Pioglitazone
Table 3. Key Players of Obeticholic Acid (OCA)
Table 4. Key Players of Lanifibranor
Table 5. Key Players of Semaglutide
Table 6. Key Players of Resmetirom
Table 7. Key Players of Aramchol
Table 8. Key Players of Cenicriviroc
Table 9. Key Players of Others
Table 10. Global Non-Alcoholic Steatohepatitis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Non-Alcoholic Steatohepatitis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Region (2019-2024)
Table 14. Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Region (2025-2030)
Table 16. Non-Alcoholic Steatohepatitis Treatment Market Trends
Table 17. Non-Alcoholic Steatohepatitis Treatment Market Drivers
Table 18. Non-Alcoholic Steatohepatitis Treatment Market Challenges
Table 19. Non-Alcoholic Steatohepatitis Treatment Market Restraints
Table 20. Global Non-Alcoholic Steatohepatitis Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 21. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Players (2019-2024)
Table 22. Global Top Non-Alcoholic Steatohepatitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis Treatment as of 2023)
Table 23. Ranking of Global Top Non-Alcoholic Steatohepatitis Treatment Companies by Revenue (US$ Million) in 2023
Table 24. Global 5 Largest Players Market Share by Non-Alcoholic Steatohepatitis Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Non-Alcoholic Steatohepatitis Treatment Product Solution and Service
Table 27. Date of Enter into Non-Alcoholic Steatohepatitis Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Non-Alcoholic Steatohepatitis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 30. Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2019-2024)
Table 31. Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 32. Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2025-2030)
Table 33. Global Non-Alcoholic Steatohepatitis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 34. Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Application (2019-2024)
Table 35. Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 36. Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Application (2025-2030)
Table 37. North America Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Europe Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Europe Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 44. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 45. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 46. Latin America Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Latin America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 48. Latin America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 49. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 50. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 51. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 52. Intercept Pharmaceuticals Company Detail
Table 53. Intercept Pharmaceuticals Business Overview
Table 54. Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product
Table 55. Intercept Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)
Table 56. Intercept Pharmaceuticals Recent Development
Table 57. Galmed Pharmaceuticals Company Detail
Table 58. Galmed Pharmaceuticals Business Overview
Table 59. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product
Table 60. Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)
Table 61. Galmed Pharmaceuticals Recent Development
Table 62. Inventiva Pharma Company Detail
Table 63. Inventiva Pharma Business Overview
Table 64. Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Product
Table 65. Inventiva Pharma Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)
Table 66. Inventiva Pharma Recent Development
Table 67. AbbVie Inc. Company Detail
Table 68. AbbVie Inc. Business Overview
Table 69. AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Product
Table 70. AbbVie Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)
Table 71. AbbVie Inc. Recent Development
Table 72. Galectin Therapeutics Inc. Company Detail
Table 73. Galectin Therapeutics Inc. Business Overview
Table 74. Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Product
Table 75. Galectin Therapeutics Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)
Table 76. Galectin Therapeutics Inc. Recent Development
Table 77. Madrigal Pharmaceuticals Company Detail
Table 78. Madrigal Pharmaceuticals Business Overview
Table 79. Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product
Table 80. Madrigal Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)
Table 81. Madrigal Pharmaceuticals Recent Development
Table 82. NGM Biopharmaceuticals Inc. Company Detail
Table 83. NGM Biopharmaceuticals Inc. Business Overview
Table 84. NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Product
Table 85. NGM Biopharmaceuticals Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)
Table 86. NGM Biopharmaceuticals Inc. Recent Development
Table 87. Novo Nordisk A/S Company Detail
Table 88. Novo Nordisk A/S Business Overview
Table 89. Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Product
Table 90. Novo Nordisk A/S Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)
Table 91. Novo Nordisk A/S Recent Development
Table 92. Bristol Myers Squibb Company Detail
Table 93. Bristol Myers Squibb Business Overview
Table 94. Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Product
Table 95. Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)
Table 96. Bristol Myers Squibb Recent Development
Table 97. Gilead Sciences Inc. Company Detail
Table 98. Gilead Sciences Inc. Business Overview
Table 99. Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Product
Table 100. Gilead Sciences Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)
Table 101. Gilead Sciences Inc. Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Alcoholic Steatohepatitis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Type: 2023 VS 2030
Figure 3. Vitamin E and Pioglitazone Features
Figure 4. Obeticholic Acid (OCA) Features
Figure 5. Lanifibranor Features
Figure 6. Semaglutide Features
Figure 7. Resmetirom Features
Figure 8. Aramchol Features
Figure 9. Cenicriviroc Features
Figure 10. Others Features
Figure 11. Global Non-Alcoholic Steatohepatitis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 12. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Application: 2023 VS 2030
Figure 13. Hospital Pharmacies Case Studies
Figure 14. Retail & Specialty Pharmacies Case Studies
Figure 15. Others Case Studies
Figure 16. Non-Alcoholic Steatohepatitis Treatment Report Years Considered
Figure 17. Global Non-Alcoholic Steatohepatitis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Non-Alcoholic Steatohepatitis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Region: 2023 VS 2030
Figure 20. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Players in 2023
Figure 21. Global Top Non-Alcoholic Steatohepatitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis Treatment as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Non-Alcoholic Steatohepatitis Treatment Revenue in 2023
Figure 23. North America Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Non-Alcoholic Steatohepatitis Treatment Market Share by Country (2019-2030)
Figure 25. United States Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Non-Alcoholic Steatohepatitis Treatment Market Share by Country (2019-2030)
Figure 29. Germany Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Share by Region (2019-2030)
Figure 37. China Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Non-Alcoholic Steatohepatitis Treatment Market Share by Country (2019-2030)
Figure 45. Mexico Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Share by Country (2019-2030)
Figure 49. Turkey Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Intercept Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
Figure 52. Galmed Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
Figure 53. Inventiva Pharma Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
Figure 54. AbbVie Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
Figure 55. Galectin Therapeutics Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
Figure 56. Madrigal Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
Figure 57. NGM Biopharmaceuticals Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
Figure 58. Novo Nordisk A/S Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
Figure 59. Bristol Myers Squibb Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
Figure 60. Gilead Sciences Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
REQUEST COMPANIES MENTIONED IN THIS REPORT
